Geron
GERN
$4.20
Share price
6.87%
Change (1 day)
64.06%
Change (1 year)
Categories
EPS for Geron (GERN)
EPS in 2023 (TTM): -$0.34
According to Geron's latest financial reports the company's current EPS (TTM) is -$0.34. In 2022 the company made an earnings per share (EPS) of -$0.36 a decrease over its 2021 EPS that were of -$0.36.
EPS history for Geron from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.34 | -5.56% |
| 2022 | -$0.36 | -0% |
| 2021 | -$0.36 | 33.33% |
| 2020 | -$0.27 | -25% |
| 2019 | -$0.36 | 140% |
| 2018 | -$0.15 | -16.67% |
| 2017 | -$0.18 | -0% |
| 2016 | -$0.18 | -1.2970366926827E+18% |
| 2015 | $0.0000000000 | -100% |
| 2014 | -$0.24 | -17.24% |
| 2013 | -$0.29 | -46.3% |
| 2012 | -$0.54 | -31.65% |
| 2011 | -$0.79 | -31.3% |
| 2010 | -$1.15 | 41.98% |
| 2009 | -$0.81 | 2.53% |
| 2008 | -$0.79 | 29.51% |
| 2007 | -$0.61 | 15.09% |
| 2006 | -$0.53 | -10.17% |
| 2005 | -$0.59 | -68.28% |
| 2004 | -$1.86 | 93.75% |
| 2003 | -$0.96 | -30.43% |
| 2002 | -$1.38 | -27.37% |
| 2001 | -$1.90 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.39 | -1,391.18% | 🇺🇸 USA |
 Incyte INCY | $1.90 | -658.82% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -$0.58 | 70.59% | 🇺🇸 USA |
 Bio-Techne TECH | $1.57 | -561.76% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | -$5.64 | 1,558.82% | 🇺🇸 USA |